Top 5 Biotech VC Deals of 2010

The first half of 2010 has drawn to a close, so it's time to look back on the biggest biotech venture capital deals so far this year. At the halfway point the leader is Archimedes Pharma, and England-based developer that has raised $100 million to support the planned roll-out of PecFent, a fentanyl nasal spray designed to treat breakthrough cancer pain. Overall, the biotech industry has raised $2.1 billion in 238 deals through the end of June 2010, according to the National Venture Capital Association. See the top 5 >>